Chemotargets

@chemotargets.com

Chemotargets is a global leader in predictive analytics solutions for pharmaceutical and biotechnology companies and research institutions.

We are pleased to announce that our colleague #Nikola_Panajotovikj, will be next week in Brussels. On 12–13 May 2026, the International Drug Repurposing Conference by @remedi4all.bsky.social and #Beacon_for_Rare_Diseases returns with #iDR26. 💊

REMEDi4ALL@remedi4all.bsky.social · 5mo ago

We're excited to welcome you to Brussels next week for #iDR26 - the 2026 International Drug Repurposing Conference! 🎟️ Final tickets are available: https://loom.ly/ToR-dtw Don't miss the opportunity to take part in this unique conference programme! 👉 Full agenda here: https://loom.ly/RA5Yss4

🚀 Chemotargets in the Spotlight: 20 Years of Innovation 🚀 We are thrilled to share that today, @lavanguardia.com has dedicated a special feature to Chemotargets, highlighting our two decades of leadership in designing drugs through computational science. www.lavanguardia.com/vida/2026030...

Chemotargets: 20 años diseñando fármacos con ciencia computacional

La validación de la FDA y el salto al diseño generativo consolidan a Chemotargets como actor global en el diseño computacional de medicamentos

lavanguardia.com

Detecting true drug-safety signals from post-marketing spontaneous reports is still a difficult task, subject to multiple biases. With #SafetyVista you can assess how reporting bias affects signal detection. Contact us for a demo trial at 👉 info@chemotargets.com.

Bild

New #SafetyVista version ✨ Augmented Safety Intelligence. Proactive Pharmacovigilance. SV offers now a set of unique analytics tools to assist in the detection, analysis and forecast of drug safety signals in both global & stratified patient (sub)populations. Interested? 👉 info@chemotargets.com

Bild